中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents

Association between genotype and phenotype of ABCB4 gene mutation

DOI: 10.3969/j.issn.1001-5256.2021.11.052
Research funding:

National Natural Science Foundation of China (81970454)

  • Received Date: 2021-03-17
  • Accepted Date: 2021-05-10
  • Published Date: 2021-11-20
  • ABCB4-related disease is the syndrome of bile secretion disorder caused by gene mutations and can cause bile duct injury, portal hypertension, and liver cirrhosis in clinical practice. With the development of genetics and gene sequencing techniques in recent years, more and more mutation sites have been identified; however, since this is a relatively complex disease, the pathogenicity and pathogenic mechanism of mutations remain unclear. Meanwhile, since this disease is rare, it is difficult to determine the pathogenicity of ABCB4 mutations based on basic research or clinical data. Therefore, it is urgent to establish the association between ABCB4 genotypes and phenotypes and construct a complete system in basic research and clinical practice.

     

  • loading
  • [1]
    STÄTTERMAYER AF, HALILBASIC E, WRBA F, et al. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults[J]. J Hepatol, 2020, 73(3): 651-663. DOI: 10.1016/j.jhep.2020.04.036.
    [2]
    ZOLNERCIKS JK, ANDRESS EJ, NICOLAOU M, et al. Structure of ABC transporters[J]. Essays Biochem, 2011, 50(1): 43-61. DOI: 10.1042/bse0500043.
    [3]
    ROSMORDUC O, HERMELIN B, BOELLE PY, et al. ABCB4 gene mutations and primary sclerosing cholangitis[J]. Gastroenterology, 2004, 126(4): 1220-1222; author reply 1222-1223. DOI: 10.1053/j.gastro.2004.02.042.
    [4]
    KUBITZ R, BODE J, ERHARDT A, et al. Cholestatic liver diseases from child to adult: The diversity of MDR3 disease[J]. Z Gastroenterol, 2011, 49(6): 728-736. DOI: 10.1055/s-0031-1273427.
    [5]
    LUCENA JF, HERRERO JI, QUIROGA J, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis[J]. Gastroenterology, 2003, 124(4): 1037-1042. DOI: 10.1053/gast.2003.50144.
    [6]
    BACQ Y, GENDROT C, PERROTIN F, et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy[J]. J Med Genet, 2009, 46(10): 711-715. DOI: 10.1136/jmg.2009.067397.
    [7]
    JACQUEMIN E, CRESTEIL D, MANOUVRIER S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy[J]. Lancet, 1999, 353(9148): 210-211. DOI: 10.1016/S0140-6736(05)77221-4.
    [8]
    ZHANG W, LIN R, LU Z, et al. Phenotypic and molecular characteristics of children with progressive familial intrahepatic cholestasis in south China[J]. Pediatr Gastroenterol Hepatol Nutr, 2020, 23(6): 558-566. DOI: 10.5223/pghn.2020.23.6.558.
    [9]
    DELAUNAY JL, DURAND-SCHNEIDER AM, DOSSIER C, et al. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3[J]. Hepatology, 2016, 63(5): 1620-1631. DOI: 10.1002/hep.28300.
    [10]
    GORDO-GILART R, ANDUEZA S, HIERRO L, et al. Functional rescue of trafficking-impaired ABCB4 mutants by chemical chaperones[J]. PLoS One, 2016, 11(2): e0150098. DOI: 10.1371/journal.pone.0150098.
    [11]
    TRAUNER M, FUCHS CD, HALILBASIC E, et al. New therapeutic concepts in bile acid transport and signaling for management of cholestasis[J]. Hepatology, 2017, 65(4): 1393-1404. DOI: 10.1002/hep.28991.
    [12]
    SCHNEIDER G, PAUS TC, KULLAK-UBLICK GA, et al. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy[J]. Hepatology, 2007, 45(1): 150-158. DOI: 10.1002/hep.21500.
    [13]
    DIXON PH, SAMBROTTA M, CHAMBERS J, et al. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy[J]. Sci Rep, 2017, 7(1): 11823. DOI: 10.1038/s41598-017-11626-x.
    [14]
    WESTBROOK RH, DUSHEIKO G, WILLIAMSON C. Pregnancy and liver disease[J]. J Hepatol, 2016, 64(4): 933-945. DOI: 10.1016/j.jhep.2015.11.030.
    [15]
    ZOLLNER G, THUERINGER A, LACKNER C, et al. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury[J]. Digestion, 2014, 90(2): 81-88. DOI: 10.1159/000365003.
    [16]
    GANNE-CARRIÉ N, BAUSSAN C, GRANDO V, et al. Progressive familial intrahepatic cholestasis type 3 revealed by oral contraceptive pills[J]. J Hepatol, 2003, 38(5): 693-694. DOI: 10.1016/s0168-8278(03)00049-7.
    [17]
    ZOLLNER G, THUERINGER A, LACKNER C, et al. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury[J]. Digestion, 2014, 90(2): 81-88. DOI: 10.1159/000365003.
    [18]
    ROSMORDUC O, HERMELIN B, POUPON R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis[J]. Gastroenterology, 2001, 120(6): 1459-1467. DOI: 10.1053/gast.2001.23947.
    [19]
    ERLINGER S. Low phospholipid-associated cholestasis and cholelithiasis[J]. Clin Res Hepatol Gastroenterol, 2012, 36(Suppl 1): s36-s40. DOI: 10.1016/S2210-7401(12)70019-0.
    [20]
    POUPON R, ROSMORDUC O, BOËLLE PY, et al. Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: A study of 156 consecutive patients[J]. Hepatology, 2013, 58(3): 1105-1110. DOI: 10.1002/hep.26424.
    [21]
    JACQUEMIN E. Progressive familial intrahepatic cholestasis[J]. Clin Res Hepatol Gastroenterol, 2012, 36(Suppl 1): s26-s35. DOI: 10.1016/S2210-7401(12)70018-9.
    [22]
    FANG LJ, WANG XH, KNISELY AS, et al. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: Clinical features and association with ABCB4 mutations[J]. J Pediatr Gastroenterol Nutr, 2012, 55(2): 150-156. DOI: 10.1097/MPG.0b013e31824ef36f.
    [23]
    SALEEM K, CUI Q, ZAIB T, et al. Evaluation of a novel missense mutation in ABCB4 gene causing progressive familial intrahepatic cholestasis type 3[J]. Dis Markers, 2020, 2020: 6292818. DOI: 10.1155/2020/6292818.
    [24]
    KHABOU B, MAHJOUB B, BARBU V, et al. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment[J]. Clin Chim Acta, 2018, 486: 122-128. DOI: 10.1016/j.cca.2018.07.035.
    [25]
    SHARMA A, PODDAR U, AGNIHOTRY S, et al. Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis[J]. BMC Gastroenterol, 2018, 18(1): 107. DOI: 10.1186/s12876-018-0835-6.
    [26]
    SCHATZ SB, JVNGST C, KEITEL-ANSELMO V, et al. Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset[J]. Hepatol Commun, 2018, 2(5): 504-514. DOI: 10.1002/hep4.1149.
    [27]
    DAWSON RJ, LOCHER KP. Structure of a bacterial multidrug ABC transporter[J]. Nature, 2006, 443(7108): 180-185. DOI: 10.1038/nature05155.
    [28]
    GORDO-GILART R, ANDUEZA S, HIERRO L, et al. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity[J]. Gut, 2015, 64(1): 147-155. DOI: 10.1136/gutjnl-2014-306896.
    [29]
    GORDO-GILART R, HIERRO L, ANDUEZA S, et al. Heterozygous ABCB4 mutations in children with cholestatic liver disease[J]. Liver Int, 2016, 36(2): 258-267. DOI: 10.1111/liv.12910.
    [30]
    AVENA A, PUGGELLI S, MORRIS M, et al. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed[J]. Dig Liver Dis, 2021, 53(3): 329-344. DOI: 10.1016/j.dld.2020.12.003.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (613) PDF downloads(53) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return